Tratamiento antirretroviral de la infección por el VIH - libdoc.who.int
Tratamiento antirretroviral de la infección por el VIH - libdoc.who.int
Tratamiento antirretroviral de la infección por el VIH - libdoc.who.int
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
120. McIntyre JA MN, Gray GE, et al. Addition of short course combivir to single-dose viramune<br />
for the prevention of mother to child transmission of HIV-1 can significantly <strong>de</strong>crease the<br />
subsequent <strong>de</strong>v<strong>el</strong>opment of maternal and paediatric NNRTI-resistant virus. 3rd<br />
International AIDS Society Conference on HIV Pathogenesis and Treatment; July 24−27,<br />
2005; Rio <strong>de</strong> Janeiro, Brazil. 2005.<br />
121. Chi BH, Sinka<strong>la</strong> M, Mbewe F, Cantr<strong>el</strong>l RA, Kruse G, Ch<strong>int</strong>u N, et al. Single-dose tenofovir<br />
and emtricitabine for reduction of viral resistance to non-nucleosi<strong>de</strong> reverse transcriptase<br />
inhibitor drugs in women given <strong>int</strong>rapartum nevirapine for perinatal HIV prevention: an<br />
open-<strong>la</strong>b<strong>el</strong> randomised trial. Lancet 2007;370(9600):1698-705.<br />
122. Van Dyke R JG, Shapiro D, et al. A phase II study of the inci<strong>de</strong>nce of nevirapine resistance<br />
mutations in HIV-infected Thai women receiving a single <strong>int</strong>rapartum dose of NVP followed<br />
by a postpartum tail of ZDV/ddI or ZDV/ddI/LPV/r: IMPAACT P1032. 16th Conference on<br />
Retroviruses and Op<strong>por</strong>tunistic Infections; February 8-11 2009; Montreal, Canada. 2009.<br />
123. Farr S NJ, Ng’ombe T, et al. Addition of 7 days of zidovudine + <strong>la</strong>mivudine to peripartum<br />
single-dose nevirapine effectiv<strong>el</strong>y reduces nevirapine resistance at 2 and 6 weeks<br />
postpartum in HIV-infected mothers. 16th Conference on Retroviruses and Op<strong>por</strong>tunistic<br />
Infections; February 8-11 2009; Montreal, Canada. 2009.<br />
124. Lallemant M JG, Ngo-Giang-Huong N, et al. Efficacy and safety of 1-month post-partum<br />
zidovudine and didanosine to prevent HIV-1 nevirapine resistance mutations following<br />
Intrapartum single-dose nevirapine. 16th Conference on Retroviruses and Op<strong>por</strong>tunistic<br />
Infections; February 8-11 2009; Montreal, Canada. 2009.<br />
125. Arrive E, Chaix ML, Nerrienet E, B<strong>la</strong>nche S, Rouzioux C, Coffie PA, et al. Tolerance and<br />
viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent<br />
vertical transmission of HIV-1. AIDS 2009;23(7):825-33.<br />
126. Marra F Bruno R, Ga<strong>la</strong>stri S eds. GP120 induces directional migration of human hepatic<br />
st<strong>el</strong><strong>la</strong>te c<strong>el</strong>ls: a link between HIV infection and liver fibrogenesis. Hepatology 2007.<br />
127. Thio CL, Seaberg EC, Sko<strong>la</strong>sky R (Jr), Phair J, Visscher B, Munoz A, et al. HIV-1, hepatitis<br />
B virus, and risk of liver-re<strong>la</strong>ted mortality in the Multicenter Cohort Study (MACS). Lancet<br />
2002;360(9349):1921-6.<br />
128. Hoffmann CJ, Seaberg EC, Young S, Witt MD, D’Acunto K, Phair J, et al. Hepatitis B and<br />
long-term HIV outcomes in coinfected HAART recipients. AIDS 2009;23(14):1881-9.<br />
129. Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, et al. A<br />
randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral<br />
naive individuals in Thai<strong>la</strong>nd. Hepatology 2008;48(4):1062-9.<br />
130. Matthews GV, Seaberg E, Dore GJ, Bow<strong>de</strong>n S, Lewin SR, Sasa<strong>de</strong>usz J, et al. Combination<br />
HBV therapy is linked to greater HBV DNA suppression in a cohort of <strong>la</strong>mivudineexperienced<br />
HIV/HBV coinfected individuals. AIDS 2009;23(13):1707-15.<br />
141
Change language